Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial

Published:2017-07-03 Issue:3 Volume:15 Page:
ISSN:1570-162X
Container-title:Current HIV Research
language:en
Short-container-title:CHR

Author:

Gallant Joel¹,Moyle Graeme²,Berenguer Juan³,Shalit Peter⁴,Cao Huyen⁵,Liu Ya-Pei⁵,Myers Joel⁶,Rosenblatt Lisa⁶,Yang Lingfeng⁷,Szwarcberg Javier⁵

Affiliation:

1. Southwest CARE Center, 649 Harkle Road, Ste. E, Santa Fe, NM, United States

2. Chelsea and Westminster Hospital, London, United Kingdom

3. Hospital General Universitario Gregorio Maranon, Madrid, Spain

4. Tribal Med, Seattle, WA, United States

5. Gilead Sciences, Inc., Foster City, CA, United States

6. Bristol-Myers Squibb, Plainsboro, NJ, United States

7. Bristol-Myers Squibb, Hopewell, NJ, United States

Publisher

Bentham Science Publishers Ltd.

Subject

Virology,Infectious Diseases

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current drugs for HIV-1: from challenges to potential in HIV/AIDS;Frontiers in Pharmacology;2023-10-26

2. Hepatotoxicity of contemporary antiretroviral drugs;Current Opinion in HIV and AIDS;2021-09-20

3. Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data;Cells;2021-05-20

4. Antiretroviral Therapy in Advanced HIV Disease: Which is the Best Regimen?;Aids Reviews;2018-04-17

5. Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2017-12-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3